Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q419944> ?p ?o }
Showing triples 1 to 69 of
69
with 100 triples per page.
- Q419944 subject Q6897536.
- Q419944 subject Q7145148.
- Q419944 subject Q7335338.
- Q419944 subject Q8919936.
- Q419944 subject Q8965786.
- Q419944 abstract "Moxonidine (INN) /mɒkˈsɒnɪdiːn/ is a new-generation centrally acting antihypertensive drug licensed for the treatment of mild to moderate essential hypertension. It may have a role when thiazides, beta-blockers, ACE inhibitors and calcium channel blockers are not appropriate or have failed to control blood pressure. In addition, it demonstrates favourable effects on parameters of the insulin resistance syndrome, apparently independent of blood pressure reduction. It is manufactured by Solvay Pharmaceuticals under the brand name Physiotens.".
- Q419944 atcPrefix "C02".
- Q419944 atcSuffix "AC05".
- Q419944 bioavailability "88.0".
- Q419944 casNumber "75438-57-2".
- Q419944 fdaUniiCode "CC6X0L40GW".
- Q419944 iupacName "4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-".
- Q419944 iupacName "6-methoxy-2-methylpyrimidin-5-amine".
- Q419944 pubchem "4810".
- Q419944 thumbnail Moxonidine.svg?width=300.
- Q419944 wikiPageWikiLink Q1053470.
- Q419944 wikiPageWikiLink Q1072.
- Q419944 wikiPageWikiLink Q1097957.
- Q419944 wikiPageWikiLink Q11085.
- Q419944 wikiPageWikiLink Q1129007.
- Q419944 wikiPageWikiLink Q159701.
- Q419944 wikiPageWikiLink Q1659850.
- Q419944 wikiPageWikiLink Q1757915.
- Q419944 wikiPageWikiLink Q181754.
- Q419944 wikiPageWikiLink Q187215.
- Q419944 wikiPageWikiLink Q189033.
- Q419944 wikiPageWikiLink Q217111.
- Q419944 wikiPageWikiLink Q288280.
- Q419944 wikiPageWikiLink Q2988775.
- Q419944 wikiPageWikiLink Q37525.
- Q419944 wikiPageWikiLink Q389934.
- Q419944 wikiPageWikiLink Q412221.
- Q419944 wikiPageWikiLink Q41571.
- Q419944 wikiPageWikiLink Q41861.
- Q419944 wikiPageWikiLink Q421700.
- Q419944 wikiPageWikiLink Q423930.
- Q419944 wikiPageWikiLink Q45959.
- Q419944 wikiPageWikiLink Q5142470.
- Q419944 wikiPageWikiLink Q575890.
- Q419944 wikiPageWikiLink Q633403.
- Q419944 wikiPageWikiLink Q658.
- Q419944 wikiPageWikiLink Q665843.
- Q419944 wikiPageWikiLink Q6897536.
- Q419944 wikiPageWikiLink Q706184.
- Q419944 wikiPageWikiLink Q7145148.
- Q419944 wikiPageWikiLink Q7335338.
- Q419944 wikiPageWikiLink Q816759.
- Q419944 wikiPageWikiLink Q824258.
- Q419944 wikiPageWikiLink Q82642.
- Q419944 wikiPageWikiLink Q844935.
- Q419944 wikiPageWikiLink Q8919936.
- Q419944 wikiPageWikiLink Q8965786.
- Q419944 wikiPageWikiLink Q9377.
- Q419944 atcPrefix "2.0".
- Q419944 atcSuffix "AC05".
- Q419944 bioavailability "88.0".
- Q419944 casNumber "75438".
- Q419944 iupacName "4".
- Q419944 iupacName "6".
- Q419944 pubchem "4810".
- Q419944 unii "CC6X0L40GW".
- Q419944 type ChemicalSubstance.
- Q419944 type Drug.
- Q419944 type ChemicalObject.
- Q419944 type Thing.
- Q419944 type Q8386.
- Q419944 comment "Moxonidine (INN) /mɒkˈsɒnɪdiːn/ is a new-generation centrally acting antihypertensive drug licensed for the treatment of mild to moderate essential hypertension. It may have a role when thiazides, beta-blockers, ACE inhibitors and calcium channel blockers are not appropriate or have failed to control blood pressure. In addition, it demonstrates favourable effects on parameters of the insulin resistance syndrome, apparently independent of blood pressure reduction.".
- Q419944 label "Moxonidine".
- Q419944 depiction Moxonidine.svg.